Published in PLoS One on January 23, 2014
Cardiac Fibrosis: The Fibroblast Awakens. Circ Res (2016) 1.21
High-fat Diet Promotes Cardiac Remodeling in an Experimental Model of Obesity. Arq Bras Cardiol (2015) 0.81
Updating experimental models of diabetic cardiomyopathy. J Diabetes Res (2015) 0.80
AT1 receptor blockade alters nutritional and biometric development in obesity-resistant and obesity-prone rats submitted to a high fat diet. Front Psychol (2014) 0.79
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy. Front Physiol (2016) 0.76
Association between echocardiographic structural parameters and body weight in Wistar rats. Oncotarget (2017) 0.75
Left Ventricular Function Across the Spectrum of Body Mass Index in African Americans: The Jackson Heart Study. JACC Heart Fail (2017) 0.75
High and Low Salt Intake during Pregnancy: Impact on Cardiac and Renal Structure in Newborns. PLoS One (2016) 0.75
Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats. Evid Based Complement Alternat Med (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation (1978) 20.37
Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol (2000) 7.17
Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev (2007) 4.23
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie (2005) 3.20
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation (2002) 2.78
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev (2010) 2.68
Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J (2005) 2.66
Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol (2008) 1.95
Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand (2005) 1.94
Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol (2007) 1.71
Impact of beta-myosin heavy chain isoform expression on cross-bridge cycling kinetics. Am J Physiol Heart Circ Physiol (2004) 1.67
Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension (2001) 1.59
Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta (2006) 1.54
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Myocardial dysfunction and abnormalities in intracellular calcium handling in obese rats. Arq Bras Cardiol (2011) 1.51
Angiotensin II and the development of insulin resistance: implications for diabetes. Mol Cell Endocrinol (2008) 1.33
The role of high-fat diets and physical activity in the regulation of body weight. Br J Nutr (2000) 1.25
Angiotensin II increases adipose angiotensinogen expression. Am J Physiol Endocrinol Metab (2007) 1.19
Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart. J Biol Chem (2007) 1.15
Phenotypic plasticity of adult myocardium: molecular mechanisms. J Exp Biol (2006) 1.08
Cardiac remodeling in a rat model of diet-induced obesity. Can J Cardiol (2010) 1.07
Alterations in myocardial collagen content affect rat papillary muscle function. Am J Physiol Heart Circ Physiol (2000) 1.07
Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression. Exp Physiol (2008) 1.05
Weight reduction and pharmacologic treatment in obese hypertensives. Am J Hypertens (2001) 1.04
AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol (2005) 1.01
Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats. Med Sci Monit (2010) 1.00
Improved systolic ventricular function with normal myocardial mechanics in compensated cardiac hypertrophy. Jpn Heart J (2004) 0.98
Extensive impact of saturated fatty acids on metabolic and cardiovascular profile in rats with diet-induced obesity: a canonical analysis. Cardiovasc Diabetol (2013) 0.98
Age-dependent changes in contraction and regional myocardial myosin heavy chain isoform expression in rats. J Appl Physiol (1985) (2004) 0.98
Technical note: an improved method to quantify nonesterified fatty acids in bovine plasma. J Anim Sci (1993) 0.96
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases. Drug Discov Today (2010) 0.96
Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats. Biol Pharm Bull (2011) 0.96
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol (2005) 0.93
The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance. Endocrinology (2003) 0.91
Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity. J Cell Physiol (2011) 0.91
AT1 receptor participates in the cardiac hypertrophy induced by resistance training in rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.90
A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity. Braz J Med Biol Res (2005) 0.89
Chronic heart failure-induced skeletal muscle atrophy, necrosis, and changes in myogenic regulatory factors. Med Sci Monit (2010) 0.88
Cardiovascular effects of captopril and enalapril in obese Zucker rats. Eur J Pharmacol (1999) 0.88
Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Hypertens Res (2005) 0.87
Differential nutritional, endocrine, and cardiovascular effects in obesity-prone and obesity-resistant rats fed standard and hypercaloric diets. Med Sci Monit (2010) 0.87
Effects of angiotensin II receptor antagonists on insulin resistance syndrome and leptin in sucrose-fed spontaneously hypertensive rats. Hypertens Res (2003) 0.87
ANG II type I receptor antagonism improved nitric oxide production and enhanced eNOS and PKB/Akt expression in hearts from a rat model of insulin resistance. Mol Cell Biochem (2010) 0.86
Insulin resistance and obesity. Clin Dermatol (2004) 0.86
Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats. Am J Physiol Endocrinol Metab (2004) 0.86
Exercise training prevents beta-adrenergic hyperactivity-induced myocardial hypertrophy and lesions. Eur J Heart Fail (2008) 0.86
Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. Atherosclerosis (2009) 0.86
Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril. Heart (2005) 0.85
Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome. Am J Hypertens (2007) 0.85
ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X. Can J Cardiol (2000) 0.83
Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems. Endocrinology (2004) 0.81
Postnatal pancreatic islet β cell function and insulin sensitivity at different stages of lifetime in rats born with intrauterine growth retardation. PLoS One (2011) 0.80
Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts. J Renin Angiotensin Aldosterone Syst (2007) 0.76
Angiotensin receptor blockers: new considerations in their mechanism of action. J Clin Hypertens (Greenwich) (2006) 0.76